Partner Violence and Anger Management

Partner Violence and Anger Management: a Randomised Controlled Study of the Effectiveness of Cognitive Behavioral Therapy

The purpose of this study is to investigate the effectiveness of the Brøset anger management model in reducing violent behavior amongst clients who are violent in intimate partnerships and who voluntarily seek help.

Violence in intimate partnerships constitutes a serious problem worldwide and there is reason to believe that cognitive behavior therapy has some effect on the reduction of violent behavior. However, there are currently too few randomized controlled studies to conclude about the effectiveness of cognitive behavior therapy for this client group.

Study Overview

Study Type

Interventional

Enrollment (Actual)

185

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Trondheim, Norway, 7440
        • St Olavs University Hospital, Division of Psychiatry, Centre for research and education in forensic psychiatry Brøset

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • fluent in Norwegian language
  • is in a partner relationship at inclusion. Partner relationship is defined by having an intimate partner at present, or being in regular contact with a former intimate partner so that violence is possible (e.g. they have children)
  • admits being violent to his partner (physical, mental and/or sexual)

Exclusion Criteria:

  • psychosis
  • alcohol- or drug addiction to a level that hinders group participation free from intoxication.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: The Brøset anger management model
Group treatment
manualised structured cognitive treatment program 15 weeks (30 hours)
ACTIVE_COMPARATOR: ordinary group treatment
Group treatment
group treatment 8 weeks (16 hours)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
violent behaviour, reported by partner and client
Time Frame: 3 months between assessments, 1 year duration, i.e. baseline and 4 follow-up assessments. In accordance with the original Norwegian protocol.
measured by using the Conflict Tactics Scale Revised (CTS2), instrument for measuring violence in intimate partnerships(10), which consists of 78 questions (0-7) about different aspects of violence (frequence of physical, psychological, sexual and material violence)
3 months between assessments, 1 year duration, i.e. baseline and 4 follow-up assessments. In accordance with the original Norwegian protocol.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The client's and their partner's mental health
Time Frame: 3 months between assessments, 1 year duration, i.e. baseline and 4 follow-up assessments. In accordance with the original Norwegian protocol.
measured by using the Hopkins Symptoms Check List (HSCL-25, with 25 questions about the presence and intensity of anxiety and depression symptoms, and symptoms of somatoform character)
3 months between assessments, 1 year duration, i.e. baseline and 4 follow-up assessments. In accordance with the original Norwegian protocol.
The client's and their partner's health service use and absence due to sickness
Time Frame: 3 months between assessments, 1 year duration, i.e. baseline and 4 follow-up assessments. In accordance with the original Norwegian protocol.
3 months between assessments, 1 year duration, i.e. baseline and 4 follow-up assessments. In accordance with the original Norwegian protocol.
Changes in emotional dysregulation
Time Frame: 3 months between assessments, 1 year duration, i.e. baseline and 4 follow-up assessments. In accordance with the original Norwegian protocol.
Emotional regulation will be assessed by the Difficulties in Emotion Regulation Scale (DERS, Gratz & Roemer, 2004).
3 months between assessments, 1 year duration, i.e. baseline and 4 follow-up assessments. In accordance with the original Norwegian protocol.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tom Palmstierna, MD PhD prof, Norwegian University of Science and Technology

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 1, 2012

Primary Completion (ACTUAL)

May 4, 2018

Study Completion (ACTUAL)

May 4, 2018

Study Registration Dates

First Submitted

July 25, 2012

First Submitted That Met QC Criteria

July 27, 2012

First Posted (ESTIMATE)

July 31, 2012

Study Record Updates

Last Update Posted (ACTUAL)

November 3, 2020

Last Update Submitted That Met QC Criteria

November 2, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 2012/683

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Domestic Violence

Clinical Trials on The Brøset anger management model

3
Subscribe